Udo Lange

USPTO Granted Patents = 47 (Patent Applications = 14)

CIPO Patents = 4 (Patent Applications = 21)

EPO Patents = 17 (Patent Applications = 25)

Average Co-Inventor Count = 7.8

ph-index = 9

Forward Citations = 231(Granted Patents)

Location History:

Mannheim, DE (2006 - 2016)
Berlin, DE (2010 - 2016)
Wiesbaden, DE (2015 - 2016)
Ludwigshafen, DE (2000 - 2020)

Company Filing History:

29 out of 167

Abbvie Deutschland Gmbh and Co Kg

Abbott Laboratories Corporation

patents

5. 2 out of 10,754

Basf Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2000-2020

Loading Chart...

Areas of Expertise:

Fused Heterocyclic Compounds

Pyrrolidine Derivatives

Aminotetraline Derivatives

Aminoindane Derivatives

Phenalkylamine Derivatives

Guanidine Compounds

Tetrahydroisoquinolines

Integrin Ligands

Thrombin Inhibitors

Aminochromane Derivatives

Heterocyclic Compounds

Serotonin Receptor Modulators

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10556907 - Fused heterocyclic compounds as S1P modulators (2020-02-11),

2. 10280159 - Fused (hetero)cyclic compounds as S1P modulators (2019-05-07),

3. 9656955 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-23),

4. 9650334 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-16),

5. 9586945 - Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-03-07),

6. 9586942 - Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-03-07),

7. 9550754 - 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-01-24),

8. 9475782 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors (2016-10-25),

9. 9365512 - Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-06-14),

10. 9309200 - Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-04-12),

11. 9296697 - [object Object] (2016-03-29),

12. 9238619 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-01-19),

13. 9227930 - Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-01-05),

14. 9096619 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy (2015-08-04),

15. 9067871 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy (2015-06-30),

Title: The Innovative Journey of Udo Lange

Introduction: Udo Lange, a visionary inventor hailing from Ludwigshafen, Germany, has made significant contributions to the world of technology and innovation.

Latest Patents: Udo Lange's latest patents focus on renewable energy solutions, sustainable materials, and cutting-edge manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for pushing the boundaries of what is possible, Udo Lange has led groundbreaking projects in the fields of clean energy, advanced materials, and smart technologies. His innovative spirit has earned him recognition as a pioneer in his field.

Collaborations: Throughout his career, Udo Lange has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work across disciplines and industries has led to the development of groundbreaking technologies with real-world applications.

Conclusion: Udo Lange's relentless pursuit of innovation and his dedication to creating a better world through technology make him a true trailblazer in the field of inventing. His work continues to inspire future generations of inventors and engineers to think boldly and push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.